Comparison of the Immunogenicity and Safety of Various Investigational and Licensed Formulations of Hepatitis B Surface Antigen (HBsAg) Vaccines
Latest Information Update: 25 Jul 2023
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 02 Aug 2012 Actual end date (1 Jul 2011) added as reported by ClinicalTrials.gov record.
- 28 Jan 2011 Planned end date changed from 1 Aug 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 16 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.